Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal intravenous tranexamic acid regimen for perioperative hip fracture surgery
ChiCTR2000032758Phase 4Not yet recruiting
- Sponsor
- Trauma Center of Daping Hospital, Army Military Medical University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in hip fracture (4 arms), sponsored by Trauma Center of Daping Hospital, Army Military Medical University. Primary endpoints: Total blood loss and Hidden blood loss. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR2000032758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032758.